Herpes simplex glycoprotein DNA vaccine (Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHerpes simplex glycoprotein DNA vaccine (Pfizer)

Drug Alias Name单纯疱疹糖蛋白病毒疫苗-Pfizer

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Simplex

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHerpes Simplex

ATC CodeN/A